Table 2.
Lower urinary tract symptoms in amyotrophic lateral sclerosis.
| Parameter | ALSpc (No) | Mean Disease Duration | Methods | Results | References |
|---|---|---|---|---|---|
| LUTS (UI) | 43 | 34.0 mo (7–246 mo) | ICIQ-SF UDI-6 |
33% | [52] |
| LUTS | 54 | 5.17 ± 5.70 y | ICS—standardized questionnaire | 40.74% | [73] |
| LUTS | 55 | 30.8 mo (5.5–294 mo) | ICIQ-SF OAB-V8 IPSS |
43.6% | [74] |
ALSpc: patients with ALS; LUTS: lower urinary tract symptoms; UI: urinary incontinence; ICIQ-SF: International Consultation on Incontinence Modular Questionnaire Short Form; UDI-6: Urinary Distress Inventory-6; ICS: International Continence Society; OAB-V8: Overactive Bladder Awareness Tool; IPSS: International Prostate Symptom Score; ALS: amyotrophic lateral sclerosis; No: number; mo: months; y: years.